All terms in GO
| Label | Id | Description |
|---|---|---|
| cell aggregation | GO_0098743 | [The clustering together and adhesion of initially separate cells to form an aggregate. Examples include the clustering of unicellular organisms or blood cells in suspension and the condensation of mesenchymal cells during cartilage formation.] |
| histamine secretion | GO_0001821 | [The regulated release of histamine by a cell or tissue. It is formed by decarboxylation of histidine and it acts through receptors in smooth muscle and in secretory systems.] |
| histamine transport | GO_0051608 | [The directed movement of histamine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Histamine is a physiologically active amine, found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans.] |
| 1-phosphatidylinositol 4-kinase activator activity | GO_0098744 | [Binds to and increases the activity of 1-phosphatidylinositol 4-kinase.] |
| Dcp1-Dcp2 complex | GO_0098745 | [A protein complex consisting of a Dcp1 regulatory subunit and a Dcp2 catalytic subunit that has mRNA cap binding activity and is involved in decapping of nuclear-transcribed mRNA.] |
| fast, calcium ion-dependent exocytosis of neurotransmitter | GO_0098746 | [The fast, initial phase of calcium ion-induced neurotransmitter release, via exocytosis, into the synaptic cleft. This depends on low affinity calcium sensors and typically begins a fraction of a millisecond after Ca2+ influx, and decays rapidly (1-10ms) with a decay constant of around 5-10ms. The underlying molecular mechanisms of this process are distinct from those of the later, slow phase of release.] |
| slow, calcium ion-dependent exocytosis of neurotransmitter | GO_0098747 | [The slow, second phase of calcium ion-induced neurotransmitter release, via exocytosis, into the synaptic cleft. This depends on high affinity calcium sensors and decays slowly, typically with a decay constant of over 100ms. The underlying molecular mechanisms of this process are distinct from those of the earlier, fast phase of release.] |
| GO_0098748 | GO_0098748 | |
| vestibular receptor cell stereocilium organization | GO_0060121 | [A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a stereocilium. A stereocilium is an actin-based protrusion from the apical surface of vestibular hair cells.] |
| vestibular receptor cell morphogenesis | GO_0060116 | [Any process that alters the size or shape of a vestibular receptor cell.] |
| female pregnancy | GO_0007565 | [The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.] |
| negative regulation of fusion cell fate specification | GO_0035157 | [Any process that restricts, stops or prevents a cell from adopting a fusion cell fate. Once the terminal and fusion fates have been correctly induced, inhibitory feedback loops prevent the remaining branch cells from assuming similar fates.] |
| fusion cell fate specification | GO_0035156 | [The process in which a cell becomes capable of differentiating autonomously into a fusion cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed. Fusion cells allow the interconnection of adjacent tracheal metameres during tracheal tube fusion.] |
| embryonic process involved in female pregnancy | GO_0060136 | [A reproductive process occurring in the embryo or fetus that allows the embryo or fetus to develop within the mother.] |
| regulation of tube diameter, open tracheal system | GO_0035158 | [Ensuring that a tube in an open tracheal system is of the correct diameter. When primary branches form their lumens are small (less than 2 micrometers) in caliber and must undergo regulated expansion during larval life to reach their mature size.] |
| regulation of tube length, open tracheal system | GO_0035159 | [Ensuring that a tube in an open tracheal system is of the correct length.] |
| somatotropin secreting cell development | GO_0060133 | [The process whose specific outcome is the progression of a somatotropin secreting cell over time, from its formation to the mature structure. A somatotropin secreting cell is an acidophilic cell of the anterior pituitary that produces growth hormone, somatotropin.] |
| negative regulation of terminal cell fate specification, open tracheal system | GO_0035155 | [Any process that restricts, stops or prevents a cell from adopting a terminal cell fate in an open tracheal system. Once the terminal and fusion fates have been correctly induced, inhibitory feedback loops prevent the remaining branch cells from assuming similar fates.] |
| terminal cell fate specification, open tracheal system | GO_0035154 | [The process in which a cell in an open tracheal system becomes capable of differentiating autonomously into a terminal cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed. Terminal cells send long and bifurcated hollow branches toward target tissues to allow oxygen exchange.] |
| prepulse inhibition | GO_0060134 | [The process in which a startle magnitude is reduced when the startling stimulus is preceded by a low-intensity prepulse.] |